Borealis to Present LDPE-based Transparent Ampoules at Pharmapack 2011
Borealis will present a polyethylene solution for self-administered easy-to-use ampoules to converters and brand owners at Pharmapack 2011 from February 23-24, 2011.
Bormed™ LE6601-PH is the latest addition to Borealis' range of healthcare application-dedicated Bormed polyolefins combining end-user and manufacturing benefits, set to take the spotlight during the annual pharmaceutical industry event.
LDPE Bormed LE6601-PH enables the development of transparent, simple to squeeze ampoules that allow users of all ages to dispense their eye, ear and nose drop treatments without professional assistance. The LDPE grade is intended for flexible, disposable ampoules that do not require post-steam sterilization.
For packaging converters, Bormed LE6601-PH allows trouble-free conversion on standard blow molding machines as well as blow, fill and seal (BFS) machines. Wall thickness and ampoule weight are easy to control thanks to its optimised molecular weight distribution that produces material with low swell. This allows difficult shapes to be formed and ensures straightforward dosing of material quantity to altogether simplify production of consistent, high quality ampoules.
From an environmental and production efficiency perspective, the easy processing creates less waste and a low energy requirement during extrusion.
The balanced properties of Bormed LE6601-PH make it suitable for use in dip-tubes in pharmaceutical sprays in addition to flexible ampoules. Packaging based on Bormed LE6601-PH can be sterilized using ethylene oxide (EtO) or gamma radiation up to 50 kGy.
Bormed products are manufactured under strict quality conditions on dedicated production lines with change control processes installed. Bormed LE6601-PH complies with European Pharmacopeia (EP) and United States Pharmacopeia (USP) standards and is Drug Master File registered.
"In response to strong market demand, we have introduced a new version of Bormed LE6601-PH which supports Borealis' commitment to broaden its Bormed line with a special focus on BFS applications," comments Thierry Chevrier, Borealis Vice President for the Business Unit Moulding. "Bormed LE6601-PH supports the growing interest in solutions for the self-administered medication market. We are pleased to present our product which delivers both end-user and manufacturing benefits to the Pharmapack 2011 audience."
Comments
Post a Comment